These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12910151)

  • 1. [Role of rhDNase in cystic fibrosis].
    Diot P; Vecellio-None L; Varaigne F; Marchand S; Lemarié E
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S171-5. PubMed ID: 12910151
    [No Abstract]   [Full Text] [Related]  

  • 2. [New pharmacological approaches: rhDNase].
    Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
    Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of rhDNase].
    Le Bourgeois M
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S147-56. PubMed ID: 12910148
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
    Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
    Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
    Spencer DA
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaco-toxicological expert report Pulmozyme rhDNase Genentech, Inc.
    Green JD
    Hum Exp Toxicol; 1994 May; 13 Suppl 1():S1-42. PubMed ID: 8031609
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis.
    Shah PL; Scott SF; Knight RA; Hodson ME
    Eur Respir J; 1996 Mar; 9(3):531-4. PubMed ID: 8730015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of airway inflammation in cystic fibrosis].
    Abély M
    Arch Pediatr; 2007 Nov; 14(11):1350-5. PubMed ID: 17702549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmozyme (Dornase alfa)].
    Töglhofer W
    Wien Klin Wochenschr; 1994; 106(8):253-6. PubMed ID: 8023518
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of the patient with mucoviscidosis].
    ;
    Rev Mal Respir; 2003 Feb; 20(1 Pt 1):149-57. PubMed ID: 12739564
    [No Abstract]   [Full Text] [Related]  

  • 14. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
    Suri R; Wallis C; Bush A; Thompson S; Normand C; Flather M; Grieve R; Metcalfe C; Lees B
    Health Technol Assess; 2002; 6(34):iii, 1-60. PubMed ID: 12583821
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
    Shak S; Capon DJ; Hellmiss R; Marsters SA; Baker CL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9188-92. PubMed ID: 2251263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation.
    Zijlstra GS; Ponsioen BJ; Hummel SA; Sanders N; Hinrichs WL; de Boer AH; Frijlink HW
    Pharm Dev Technol; 2009; 14(4):358-68. PubMed ID: 19552563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respirable mass: vague and indefinable in disease.
    Smaldone GC; Diot P; Groth M; Ilowite J
    J Aerosol Med; 1998; 11 Suppl 1():S105-11. PubMed ID: 10180720
    [No Abstract]   [Full Text] [Related]  

  • 19. Aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Rubin BK
    N Engl J Med; 1992 Aug; 327(8):571. PubMed ID: 1635583
    [No Abstract]   [Full Text] [Related]  

  • 20. rhDNase in cystic fibrosis.
    Range SP; Knox AJ
    Thorax; 1995 Apr; 50(4):321-2. PubMed ID: 7785000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.